Diphenyl diselenide (PhSe)2 inhibits biofilm formation by Candida albicans, increasing both ROS production and membrane permeability

被引:40
作者
Rosseti, Isabela Bueno [1 ]
Teixeira Rocha, Joao Batista [2 ]
Costa, Maricilia Silva [1 ]
机构
[1] Univ Vale Paraiba UNIVAP, IP&D, BR-12244000 Sao Jose Dos Campos, SP, Brazil
[2] Univ Fed Santa Maria, Dept Quim, Ctr Ciencias Nat & Exatas, Santa Maria, RS, Brazil
基金
巴西圣保罗研究基金会;
关键词
Candida albicans; Organochalcogenides (PhSe)(2); Biofilm formation; oxidative stress; GLUTATHIONE-PEROXIDASE; DRUG-RESISTANCE; ORGANOSELENIUM; TOXICOLOGY; EBSELEN; CELLS; METHYLMERCURY; GENOTOXICITY; PHARMACOLOGY; MORTALITY;
D O I
10.1016/j.jtemb.2014.08.001
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Project: The opportunistic fungal Candida albicans can produce superficial and systemic infections in immunocompromised patients. An essential stage to both colonization and virulence by C. albicans is the transition from budding yeast form to filamentous form, producing biofilms. Procedure: In this work, we studied the effect of the organochalcogenide compound (PhSe)(2) on both cell growth and biofilm formation by C. albicans. Results: (PhSe)(2) inhibited both growth and biofilm formation by C. albicans. The inhibitory effects of (PhSe)2 depended on the cell density and (PhSe)(2) concentration. We have also observed that (PhSe)(2) stimulated ROS production (67%) and increased cell membrane permeability (2.94-fold) in C. albicans. In addition, (PhSe)(2) caused a marked decrease in proteinase activity (6.8-fold) in relation to non-treated group. Conclusions: (PhSe)(2) decreased both cell growth and biofilm development, decreasing the release of extracellular proteinases, which is an important facet of C. albicans pathogenicity. The toxicity of (PhSe)(2) towards C. albicans can be associated with an increase in ROS production, which can increase cell permeability. The permanent.damage to the cell membranes can culminate in cell death. (C) 2014 Elsevier GmbH. All rights reserved.
引用
收藏
页码:289 / 295
页数:7
相关论文
共 46 条
[1]   Two unlike cousins: Candida albicans and C.glabrata infection strategies [J].
Brunke, Sascha ;
Hube, Bernhard .
CELLULAR MICROBIOLOGY, 2013, 15 (05) :701-708
[2]  
Bueno CD, 2013, BIOMED RES INT, V2013
[3]   Treatment of Candida infection:: a view from the trenches! [J].
Bustamante, CI .
CURRENT OPINION IN INFECTIOUS DISEASES, 2005, 18 (06) :490-495
[4]   Candida albicans drug resistance -: another way to cope with stress [J].
Cannon, Richard D. ;
Lamping, Erwin ;
Holmes, Ann R. ;
Niimi, Kyoko ;
Tanabe, Koichi ;
Niimi, Masakazu ;
Monk, Brian C. .
MICROBIOLOGY-SGM, 2007, 153 :3211-3217
[5]   Candida biofilms associated with CVC and medical devices [J].
Chandra, Jyotsna ;
Mukherjee, Pranab K. ;
Ghannoum, Mahmoud A. .
MYCOSES, 2012, 55 :46-57
[6]   Diphenyl diselenide, a simple organoselenium compound, decreases methylmercury-induced cerebral, hepatic and renal oxidative stress and mercury deposition in adult mice [J].
de Freitas, Andressa Sausen ;
Funck, Vinicius Rafael ;
Rotta, Mariana dos Santos ;
Bohrer, Denise ;
Morschbacher, Vanessa ;
Puntel, Robson Luis ;
Nogueira, Cristina Wayne ;
Farina, Marcelo ;
Aschner, Michael ;
Teixeira Rocha, Joao Batista .
BRAIN RESEARCH BULLETIN, 2009, 79 (01) :77-84
[7]   FILAMENTOUS GROWTH AND ELEVATED VAGINOPATHIC POTENTIAL OF A NONGERMINATIVE VARIANT OF CANDIDA-ALBICANS EXPRESSING LOW VIRULENCE IN SYSTEMIC INFECTION [J].
DEBERNARDIS, F ;
ADRIANI, D ;
LORENZINI, R ;
PONTIERI, E ;
CARRUBA, G ;
CASSONE, A .
INFECTION AND IMMUNITY, 1993, 61 (04) :1500-1508
[8]   Nosocomial bloodstream infections in United States hospitals: A three-year analysis [J].
Edmond, MB ;
Wallace, SE ;
McClish, DK ;
Pfaller, MA ;
Jones, RN ;
Wenzel, RP .
CLINICAL INFECTIOUS DISEASES, 1999, 29 (02) :239-244
[9]   GLUTATHIONE PEROXIDASE - SELENOENZYME [J].
FLOHE, L ;
GUNZLER, WA ;
SCHOCK, HH .
FEBS LETTERS, 1973, 32 (01) :132-134
[10]   CANDIDEMIA IN A TERTIARY CARE HOSPITAL - EPIDEMIOLOGY, RISK-FACTORS, AND PREDICTORS OF MORTALITY [J].
FRASER, VJ ;
JONES, M ;
DUNKEL, J ;
STORFER, S ;
MEDOFF, G ;
DUNAGAN, WC .
CLINICAL INFECTIOUS DISEASES, 1992, 15 (03) :414-421